B. Savani

发表

Impact of pre‐transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation

W. Wood, M. Aljurf, J. Szer, 2017, Cancer.

and acute and chronic myeloid leukemia PRAME-specific peptides in patients with acute lymphoblastic leukemia Ex-vivo characterization of polyclonal memory CD8+ T-cell responses to

K. Rezvani, K. Keyvanfar, A. Barrett, 2013 .

Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow Transplantation.

Jeffrey A. Cohen, H. Atkins, K. Sullivan, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Graft‐versus‐host disease risk after chimeric antigen receptor T‐cell therapy: the diametric opposition of T cells

K. Sanber, B. Savani, T. Jain, 2021, British journal of haematology.

Childhood to adult transition and long-term follow-up after blood and marrow transplantation

S. Hashmi, B. Savani, M. Cupit, 2016, Bone Marrow Transplantation.

Late Cardiovascular Morbidity and Mortality Following Pediatric Allogeneic Hematopoietic Cell Transplantation

B. Shaw, M. Flowers, Paul L Martin, 2018, Bone Marrow Transplantation.

Transgender individuals represent an overlooked population amongst stem cell donors

B. Savani, B. Adkins, Garrett S. Booth, 2019, Bone Marrow Transplantation.

Survival following allogeneic transplant in patients with myelofibrosis.

N. Kröger, M. Arcasoy, S. Verstovsek, 2020, Blood advances.

Pretransplantation C-Peptide level predicts early posttransplantation diabetes mellitus and has an impact on survival after allogeneic stem cell transplantation.

Heidi Chen, A. Kassim, B. Savani, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effects of bortezomib on the immune system: a focus on immune regulation.

M. Mohty, B. Gaugler, B. Savani, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Ex vivo characterization of polyclonal memory CD8+ T-cell responses to PRAME-specific peptides in patients with acute lymphoblastic leukemia and acute and chronic myeloid leukemia.

K. Rezvani, K. Keyvanfar, A. Barrett, 2009, Blood.

Long-term survival and late events after allogeneic stem cell transplantation from HLA-matched siblings for acute myeloid leukemia with myeloablative compared to reduced-intensity conditioning

J. Sierra, M. Labopin, A. Nagler, 2022 .

Donor KIR Genes 2DL5A, 2DS1 and 3DS1 are associated with a reduced rate of leukemia relapse after HLA-identical sibling stem cell transplantation for acute myeloid leukemia but not other hematologic malignancies.

Marcela R. Uribe, S. Adams, A. Barrett, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The role of nutrition and effects on the cytokine milieu in allogeneic hematopoietic stem cell transplantation.

B. Savani, Lauren Zatarain, 2012, Cellular immunology.

Human leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: a report from the Center for International Blood and Marrow Transplant Research

M. Horowitz, J. Pidala, Stephanie J. Lee, 2016, Haematologica.

Improved outcome for peripheral blood stem cell transplantation for advanced primary myelodysplastic syndrome.

A. Barrett, R. Childs, E. Read, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Management of relapses after hematopoietic cell transplantation in T-cell non-Hodgkin lymphomas.

S. Usmani, B. Savani, M. Kharfan-Dabaja, 2014, Seminars in hematology.

Role of bridging therapy during chimeric antigen receptor T cell therapy

O. Oluwole, B. Savani, B. Dholaria, 2021, EJHaem.

Utilization of Chimeric Antigen Receptor (CAR) T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B cell non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.

M. Bar, F. Awan, D. Miklos, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Imatinib synergizes with donor lymphocyte infusions to achieve rapid molecular remission of CML relapsing after allogeneic stem cell transplantation

A. Barrett, N. Hensel, R. Childs, 2005, Bone Marrow Transplantation.

Does recipient body mass index inform donor selection for allogeneic haematopoietic cell transplantation?

M. Sorror, M. Pasquini, H. Lazarus, 2022, British journal of haematology.

The evolving role of allogeneic haematopoietic cell transplantation in the era of chimaeric antigen receptor T‐cell therapy

M. Perales, A. Nagler, M. Mohty, 2021, British journal of haematology.

Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies.

K. Rezvani, A. Barrett, S. Mielke, 2007, Blood.

Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)–an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT)

M. Bar, G. Mufti, S. Grupp, 2019, Bone Marrow Transplantation.

Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow Transplantation.

M. Bar, G. Mufti, S. Grupp, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

CD19 chimeric antigen receptor-T cells in B-cell leukemia and lymphoma: current status and perspectives

M. Perales, A. Nagler, M. Mohty, 2019, Leukemia.

Second allogeneic stem cell transplantation in patients with acute lymphoblastic leukaemia: a study on behalf of the Acute Leukaemia Working Party of the European Society for Blood and Marrow Transplantation

M. Labopin, A. Nagler, M. Mohty, 2019, British journal of haematology.

Allogeneic haematopoietic cell transplantation after CAR T‐cell therapy: safe, effective and contentious

B. Savani, B. Dholaria, 2019, British journal of haematology.

GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia.

M. Aljurf, J. Szer, R. Gale, 2019, Blood advances.

Influence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for Prophylaxis.

M. Aljurf, M. Horowitz, R. Gale, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Peripheral blood stem cell versus bone marrow transplantation: A perspective from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

A. Nagler, M. Mohty, B. Savani, 2016, Experimental hematology.

Providing personalized prognostic information for adult leukemia survivors.

Alan M. Miller, B. Storer, B. George, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria

A. Kassim, J. Greer, B. Savani, 2012, Bone Marrow Transplantation.

Allogeneic Transplantation to Treat Therapy Related MDS and AML in Adults.

Christopher G. Kanakry, B. Sandmaier, C. Hourigan, 2021, Transplantation and cellular therapy.

Hematopoietic Cell Transplantation in the Treatment of Newly Diagnosed Adult Acute Myeloid Leukemia: An Evidence-Based Review from the American Society of Transplantation and Cellular Therapy.

M. Perales, A. Nagler, M. Mohty, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

FLAMSA-based reduced intensity conditioning versus myeloablative conditioning in younger patients with relapsed/refractory acute myeloid leukemia with active disease at the time of allogeneic stem cell transplantation: an ALWP/EBMT analysis.

A. Ganser, N. Kröger, M. Labopin, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effect of the Thiotepa Dose in the TBF Conditioning Regimen in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Complete Remission: A Report From the EBMT Acute Leukemia Working Party.

M. Labopin, A. Nagler, M. Mohty, 2020, Clinical lymphoma, myeloma & leukemia.

Post-transplant cyclophosphamide versus anti-thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemia

M. Labopin, A. Nagler, M. Mohty, 2020, Haematologica.

Total body irradiation + fludarabine compared to busulfan + fludarabine as “reduced-toxicity conditioning” for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT

A. Ganser, J. Johansson, R. Fanin, 2020, Bone Marrow Transplantation.

Fludarabine/busulfan versus fludarabine/total-body-irradiation (2 Gy) as conditioning prior to allogeneic stem cell transplantation in patients (≥60 years) with acute myelogenous leukemia: a study of the acute leukemia working party of the EBMT

M. Labopin, H. Sengeløv, D. Blaise, 2019, Bone Marrow Transplantation.

OUTCOME OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS OVER 69 YEARS OF AGE WITH ACUTE MYELOID LEUKEMIA: ON BEHALF OF THE ACUTE LEUKEMIA WORKING PARTY OF THE EBMT.

A. Ganser, N. Kröger, M. Labopin, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic haemopoietic transplantation for acute myeloid leukaemia in second complete remission: a registry report by the Acute Leukaemia Working Party of the EBMT

C. Craddock, M. Labopin, I. Yakoub-Agha, 2019, Leukemia.

Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma.

J. Fay, W. Wood, J. Maciejewski, 2018, Leukemia research.

Bone Health Management After Hematopoietic Cell Transplantation: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.

M. Bar, S. Ott, A. Nagler, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Neighborhood-Poverty and Pediatric Allogeneic Hematopoietic Cell Transplantation Outcomes: A CIBMTR Analysis.

W. Wood, M. Aljurf, A. Yoshimi, 2020, Blood.

Leveraging JAK-STAT regulation in myelofibrosis to improve outcomes with allogeneic hematopoietic stem-cell transplant

B. Savani, M. Savona, M. Byrne, 2018, Therapeutic advances in hematology.

Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improves Transplant Outcomes in Older MDS Patients.

M. Aljurf, J. Szer, R. Gale, 2021, Transplantation and cellular therapy.

A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Myelodysplastic Syndromes Patients.

R. Vij, W. Wood, M. Aljurf, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Decision-analytic modeling as a tool for selecting optimal therapy incorporating hematopoietic stem cell transplantation in patients with hematological malignancy

A. Nagler, M. Mohty, R. Shouval, 2020, Bone Marrow Transplantation.

Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States

W. Wood, A. Gratwohl, M. Aljurf, 2020, Cancer.

Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome.

Alan M. Miller, R. Vij, W. Wood, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Allogeneic stem cell transplantation for myelodysplastic syndrome.

A. Barrett, B. Savani, A. Barrett, 2008, Seminars in hematology.

Risk factors for hemolytic transfusion reactions resulting from ABO and minor red cell antigen incompatibility: From mislabeled samples to stem cell transplant and sickle cell disease.

E. Gehrie, B. Savani, Garrett S. Booth, 2020, Blood reviews.

Achieving early molecular response in chronic myeloid leukemia in chronic phase to reduce the risk of progression: clinical relevance of the 3‐ and 6‐month time points

M. Mohty, B. Savani, A. Yong, 2015, European journal of haematology.

A retrospective cost analysis of the frequency and cost of transfusion premedications

S. Rubinstein, B. Savani, Garrett S. Booth, 2019, Transfusion.

Impact of Pretransplantation Renal Dysfunction on Outcomes after Allogeneic Hematopoietic Cell Transplantation.

M. Sorror, M. Krem, M. Pasquini, 2021, Transplantation and cellular therapy.

Challenges and Advances in Chimeric Antigen Receptor Therapy for Acute Myeloid Leukemia

B. Savani, B. Dholaria, J. Marvin-Peek, 2022, Cancers.

Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy: Guidelines for Hematopoietic Transplantation and Cellular Therapy.

S. Crawford, P. Veys, R. Champlin, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes Compared with Fludarabine and Busulfan after Allogeneic Stem Cell Transplantation for B Cell Malignancies.

A. Kassim, J. Greer, B. Savani, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

ALTERNATIVE DONORS EXTEND TRANSPLANTATION FOR PATIENTS WITH LYMPHOMA WHO LACK AN HLA MATCHED DONOR

S. Montoto, Sonali M. Smith, D. Maloney, 2014, Bone Marrow Transplantation.

Long-term survival and late effects among one-year survivors of second allogeneic hematopoietic cell transplantation for relapsed acute leukemia and myelodysplastic syndromes.

M. Norkin, W. Wood, M. Sorror, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Does chemotherapy modify the immune surveillance of hematological malignancies?

B. Savani, A. Barrett, A. Barrett, 2009, Leukemia.

Guideline Role of Cytotoxic Therapy with Hematopoietic Cell Transplantation in the Treatment of Hodgkin Lymphoma : Guidelines from the American Society for Blood and Marrow Transplantation

J. Vose, M. Perales, A. Evens, 2015 .

Role of cytotoxic therapy with hematopoietic cell transplantation in the treatment of Hodgkin lymphoma: guidelines from the American Society for Blood and Marrow Transplantation.

J. Vose, M. Perales, A. Evens, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Managing Hodgkin lymphoma relapsing after autologous hematopoietic cell transplantation: a not-so-good cancer after all!

B. Savani, M. Kharfan-Dabaja, H. Sibai, 2014, Bone Marrow Transplantation.

Lower GVHD and relapse risk in PTCy-based Haploidentical vs Matched Sibling Donor RIC Transplant for Hodgkin Lymphoma

M. Aljurf, J. Bolaños-Meade, Y. Nieto, 2019 .

Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure

J. Vose, Sonali M. Smith, R. Vij, 2018, Cancer.

Outcomes of autologous or allogeneic stem cell transplantation for non-Hodgkin lymphoma.

O. Oluwole, J. Greer, B. Savani, 2014, Experimental hematology.

Impact of pretransplantation conditioning regimens on outcomes of allogeneic transplantation for chemotherapy-unresponsive diffuse large B cell lymphoma and grade III follicular lymphoma.

S. Montoto, P. Hari, D. Maloney, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Consolidative therapy with stem cell transplantation improves survival of patients with mantle cell lymphoma after any induction regimen.

A. Kassim, S. Brandt, O. Oluwole, 2012, Experimental hematology.

Can Routine Posttransplant HPV Vaccination Prevent Commonly Occurring Epithelial Cancers after Allogeneic Stem Cell Transplantation?

A. Barrett, J. Barrett, B. Savani, 2009, Clinical Cancer Research.

Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients

H. Kantarjian, G. Garcia-Manero, J. Cortes, 2020, Leukemia & lymphoma.

Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia.

R. Gale, H. Khoury, U. Popat, 2018, Blood advances.

Lenalidomide vs bortezomib maintenance choice post-autologous hematopoietic cell transplantation for multiple myeloma

S. Phillips, A. Kassim, R. Cornell, 2018, Bone Marrow Transplantation.

Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients

J. Esteve, A. Ganser, C. Craddock, 2020, Bone Marrow Transplantation.

Venous thromboembolism in hematopoietic stem cell transplant recipients

A. Nagler, M. Mohty, A. Neff, 2016, Bone Marrow Transplantation.

Clinical guide to fertility preservation in hematopoietic cell transplant recipients

M. Sorror, J. Wingard, J. Pidala, 2014, Bone Marrow Transplantation.

Weighty choices: selecting optimal G-CSF doses for stem cell mobilization to optimize yield.

J. Wingard, T. Spitzer, B. Shaw, 2020, Blood advances.

Increased risk of bone loss without fracture risk in long-term survivors after allogeneic stem cell transplantation.

A. Barrett, R. Childs, B. Savani, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Transplant to treatment-free remission: the evolving view of ‘cure’ in chronic myeloid leukemia

M. Mohty, S. Rubinstein, B. Savani, 2015, Expert review of hematology.

Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR).

M. Sorror, J. Wingard, M. Gilleece, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long‐term follow‐up program and transplant clinic setup

A. Tichelli, S. Hashmi, N. Majhail, 2021 .

Conditioning chemotherapy dose adjustment in obese patients: a review and position statement by the American Society for Blood and Marrow Transplantation practice guideline committee.

M. Perales, J. Wingard, J. Pidala, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Graft-versus-leukemia effects associated with detectable Wilms tumor-1 specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia.

D. Douek, K. Rezvani, K. Keyvanfar, 2007, Blood.

The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation

S. Solomon, D. Blaise, A. Nagler, 2019, Bone Marrow Transplantation.

Late effects in hematopoietic cell transplant recipients with acquired severe aplastic anemia: a report from the late effects working committee of the center for international blood and marrow transplant research.

W. Wood, M. Sorror, M. Aljurf, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Female long-term survivors after allogeneic hematopoietic stem cell transplantation: evaluation and management.

P. Stratton, M. Merideth, M. Battiwalla, 2012, Seminars in hematology.

Hematopoietic cell transplantation consideration for Philadelphia-like acute lymphoblastic leukemia patients.

M. Mohty, M. Aljurf, B. Savani, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of autologous blood transfusion after bone marrow harvest on unrelated donor’s health and outcome: a CIBMTR analysis

M. Norkin, J. Wingard, J. Liesveld, 2020, Bone Marrow Transplantation.

Role of Physical Therapy before and after Hematopoietic Stem Cell Transplantation: White Paper Report.

M. Aljurf, G. Basak, N. Chaudhri, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Sexual health in hematopoietic stem cell transplant recipients

M. Mohty, B. Shaw, P. Stratton, 2015, Cancer.

Autologous hematopoietic cell transplantation for multiple myeloma patients with renal insufficiency: A Center for International Blood and Marrow Transplant Research Analysis

A. Krishnan, P. Hari, R. Kyle, 2017, Bone Marrow Transplantation.

Clinical and Biological Predictors of Outcome Following Relapse of Chronic Myeloid Leukemia after Allogeneic Stem Cell Transplantation

K. Rezvani, P. Muranski, K. Keyvanfar, 2014, Bone marrow transplantation.

Sources of Hematopoietic Stem and Progenitor Cells and Methods to Optimize Yields for Clinical Cell Therapy.

D. Stroncek, B. Savani, S. Panch, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Systemic Sclerosis as an Indication for Autologous Hematopoietic Cell Transplantation: Position Statement from the American Society for Blood and Marrow Transplantation.

K. Sullivan, L. Crofford, M. Pasquini, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study.

W. Wood, P. Hari, A. Dispenzieri, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

New cancers after autotransplantations for multiple myeloma.

A. Krishnan, S. Lonial, P. Hari, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Sequential Intensified Conditioning Regimen Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Intermediate- or High-Risk Acute Myeloid Leukemia in Complete Remission: A Study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

A. Ganser, N. Kröger, M. Labopin, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Post-Transplant Outcomes in High-Risk Compared with Non-High-Risk Multiple Myeloma: A CIBMTR Analysis.

A. Krishnan, P. Hari, R. Kyle, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Time to explore preventive and novel therapies for bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation.

B. Savani, M. Jagasia, S. Srivastava, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Tissue-specific regulatory T cells: biomarker for acute graft-vs-host disease and survival.

J. Crowe, M. Rock, S. Yoder, 2012, Experimental hematology.

Regulatory T cell expression of CLA or α4β7 and skin or gut acute GVHD outcomes

J. Crowe, M. Rock, S. Yoder, 2011, Bone Marrow Transplantation.

Reconstitution of FOXP 3 regulatory T cells ( Tregs ) after CD 25-depleted allotransplantion in elderly patients and association with acute graft-versus-host disease

K. Rezvani, A. Barrett, V. Ghetie, 2007 .

Reconstitution of FOXP3+ regulatory T cells (Tregs) after CD25-depleted allotransplantation in elderly patients and association with acute graft-versus-host disease.

K. Rezvani, A. Barrett, V. Ghetie, 2007, Blood.

Making inroads to the cure: Barriers to clinical trial enrollment in hematopoietic cell transplantation

B. Savani, M. Byrne, Nathalie C Danielson, 2017, Clinical transplantation.

Hepatitis B Reactivation in Patients with Hematological Malignancies and Stem Cell Transplantation

B. Savani, N. Reddy, 2014 .

Establishing an autologous versus allogeneic hematopoietic cell transplant program in nations with emerging economies.

M. Aljurf, Q. Bashir, N. Chaudhri, 2017, Hematology/oncology and stem cell therapy.

Revised International Staging System Is Predictive and Prognostic for Early Relapse (<24 months) after Autologous Transplantation for Newly Diagnosed Multiple Myeloma.

P. Hari, R. Kyle, Shaji K. Kumar, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Primitive quiescent CD34+ cells in chronic myeloid leukemia are targeted by in vitro expanded natural killer cells, which are functionally enhanced by bortezomib.

K. Keyvanfar, S. Adams, A. Barrett, 2009, Blood.

Non-Graft-versus-Host Disease Ocular Complications after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European S

M. Aljurf, R. Gale, N. Callander, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT

M. Aljurf, R. Gale, N. Callander, 2019, Bone Marrow Transplantation.

acute lymphoblastic leukemia specific T lymphocytes after allogeneic stem-cell transplantation for - Graft-versus-leukemia effects associated with detectable Wilms tumor-1

D. Douek, K. Keyvanfar, S. Mielke, 2013 .

acute lymphoblastic leukemia specific T lymphocytes after allogeneic stem-cell transplantation for − Graft-versus-leukemia effects associated with detectable Wilms tumor

D. Douek, K. Rezvani, K. Keyvanfar, 2007 .

M. Bar, G. Mufti, S. Grupp, 2021 .

Bleeding and Thrombotic Complications

Shruti Chaturvedi, B. Savani, B. George, 2018, The EBMT Handbook.

Controversies about immunoglobulin replacement therapy in HSCT recipients with hypogammaglobulinemia

H. Einsele, B. Savani, A. Ohmoto, 2022, Bone Marrow Transplantation.

Combination therapy with rFVIIa and platelets for hemorrhage in patients with severe thrombocytopenia and alloimmunization

C. Dunbar, B. Savani, M. Rick, 2006, American journal of hematology.

How we manage JAK inhibition in allogeneic transplantation for myelofibrosis

M. Mohty, T. Ballinger, Vikas Gupta, 2015, European journal of haematology.

Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow transplant research.

Alan M. Miller, M. Norkin, P. Hari, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Vitamin D deficiency, autoimmunity, and graft-versus-host-disease risk: Implication for preventive therapy.

M. Mohty, B. Savani, Mona Benrashid, 2012, Experimental hematology.

Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT

A. Kassim, B. Savani, M. Jagasia, 2011, Bone Marrow Transplantation.

Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR® study

E. Guinan, M. Boeckh, M. Aljurf, 2016, Bone Marrow Transplantation.

driven graft-versus-leukemia effects - peptide following allogeneic stem cell transplantation and may improve PR1 chronic myeloid leukemia is associated with improved outcome High PR3 or ELA2 expression by CD34+ cells in advanced-phase

K. Rezvani, A. Barrett, S. Mielke, 2013 .

High PR3 or ELA2 expression by CD34+ cells in advanced-phase chronic myeloid leukemia is associated with improved outcome following allogeneic stem cell transplantation and may improve PR1 peptide-driven graft-versus-leukemia effects.

K. Rezvani, A. Barrett, J. Goldman, 2007, Blood.

Cytotoxic T-lymphocyte antigen-4 single nucleotide polymorphisms are not associated with outcomes after unrelated donor transplantation: a center for international blood and marrow transplant research analysis.

Stephanie J. Lee, S. Spellman, Tao Wang, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

How we can mitigate the side effects associated with systemic glucocorticoid after allogeneic hematopoietic cell transplantation

A. Nagler, M. Mohty, B. Savani, 2021, Bone Marrow Transplantation.

New allergies after cord blood transplantation.

A. Kassim, H. Frangoul, J. Greer, 2013, Cytotherapy.

Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma.

J. Vose, M. Aljurf, R. Gale, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Foiling fungal disease post hematopoietic cell transplant: review of prophylactic strategies

S. Rubinstein, B. Savani, K. Culos, 2018, Bone Marrow Transplantation.

Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation

A. Krishnan, W. Wood, P. Hari, 2015, Bone Marrow Transplantation.

Trends in utilization and outcomes of autologous transplantation as early therapy for multiple myeloma.

A. Krishnan, S. Lonial, R. Vij, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hyperglycemia as a possible risk factor for mold infections—the potential preventative role of intensified glucose control in allogeneic hematopoietic stem cell transplantation

H. Einsele, J. Löffler, B. Savani, 2017, Bone Marrow Transplantation.

Evaluation of six different types of sequential conditioning regimens for allogeneic stem cell transplantation in relapsed/refractory acute myelogenous leukemia – a study of the Acute Leukemia Working Party of the EBMT

A. Ganser, N. Kröger, M. Labopin, 2020, Leukemia & lymphoma.

Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemia

A. Ganser, M. Labopin, I. Yakoub-Agha, 2020, Blood Cancer Journal.

Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies.

M. Norkin, W. Wood, M. Aljurf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Treatment options for transformed lymphoma: incorporating allogeneic stem cell transplantation in a multimodality approach.

B. Savani, N. Reddy, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The use of venetoclax‐based salvage therapy for post‐hematopoietic cell transplantation relapse of acute myeloid leukemia

R. Jayani, A. Kassim, B. Savani, 2020, American journal of hematology.

The devil is in the T cells: relapsing after haploidentical hematopoietic cell transplantation

B. Savani, M. Byrne, Michael Byrne, 2016, Bone Marrow Transplantation.

Clinical and biological predictors of outcome following relapse of CML post-allo-SCT

P. Muranski, K. Keyvanfar, C. Hourigan, 2015, Bone Marrow Transplantation.

malignancies combined PR1 and WT1 peptide vaccination in patients with myeloid Leukemia-associated antigen-specific T-cell responses following

K. Rezvani, A. Barrett, S. Mielke, 2008 .

Hematopoietic stem cells and progenitors of chronic myeloid leukemia express leukemia-associated antigens: implications for the graft-versus-leukemia effect and peptide vaccine-based immunotherapy

K. Keyvanfar, A. Barrett, J. Goldman, 2008, Leukemia.

Cord blood transplantation is associated with good outcomes in secondary Acute Myeloid Leukaemia in first remission

F. Baron, M. Labopin, P. Chevallier, 2019, Journal of internal medicine.

Conditioning intensity in secondary AML with prior myelodysplastic syndrome/myeloproliferative disorders: an EBMT ALWP study.

J. Esteve, A. Ganser, G. Mufti, 2018, Blood advances.

Transplant Outcomes for Secondary Acute Myeloid Leukemia: Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation Study.

J. Esteve, A. Ganser, G. Mufti, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Management of T-cell lymphomas: overcoming challenges and choosing the best treatment.

B. Savani, N. Reddy, 2014, Seminars in hematology.

Superior long-term outcome of patients with early transformation of non-Hodgkin lymphoma undergoing stem cell transplantation.

O. Oluwole, J. Greer, B. Savani, 2012, Clinical lymphoma, myeloma & leukemia.

Primary central nervous system lymphoma: implication of high-dose chemotherapy followed by auto-SCT

B. Savani, N. Reddy, 2012, Bone Marrow Transplantation.

Long-term survival outcomes of reduced-intensity allogeneic or autologous transplantation in relapsed grade 3 follicular lymphoma

Sonali M. Smith, N. Kröger, P. Hari, 2015, Bone Marrow Transplantation.

Management of relapse after allo-SCT for AML and the role of second transplantation

S. Mielke, K. Rezvani, B. Savani, 2009, Bone Marrow Transplantation.

Differential Interaction of Peripheral Blood Lymphocyte Counts (ALC) With Different in vivo Depletion Strategies in Predicting Outcomes of Allogeneic Transplant: An International 2 Center Experience

G. Mufti, D. Mclornan, A. Kassim, 2019, Front. Oncol..

J. Szer, B. George, R. Gale, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of fludarabine–melphalan and fludarabine–treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation—a registry study on behalf of the EBMT Acute Leukemia Working Party

C. Craddock, M. Labopin, A. Nagler, 2022, Bone Marrow Transplantation.

A stitch in time saves nine… MRD‐based pre‐emptive therapy

M. Gilleece, B. Savani, 2020, British journal of haematology.

Measurable residual disease (MRD) testing for acute leukemia in EBMT transplant centers: a survey on behalf of the ALWP of the EBMT

J. Esteve, F. Baron, M. Labopin, 2020, Bone Marrow Transplantation.

Halfway there: the past, present and future of haploidentical transplantation

B. Savani, B. Fakhri, R. Romee, 2017, Bone Marrow Transplantation.

Prediction and prevention of transplant-related mortality from pulmonary causes after total body irradiation and allogeneic stem cell transplantation.

S. Solomon, A. Barrett, R. Childs, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced intensity conditioning is superior to nonmyeloablative conditioning for older chronic myelogenous leukemia patients undergoing hematopoietic cell transplant during the tyrosine kinase inhibitor era.

H. Kohrt, R. Vij, M. Aljurf, 2012, Blood.

First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation.

J. Wingard, K. Ballen, Y. Nieto, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The impact of HLA-matching on reduced intensity conditioning regimen unrelated donor allogeneic stem cell transplantation for acute myeloid leukemia in patients above 50 years—a report from the EBMT acute leukemia working party

A. Ganser, N. Kröger, C. Craddock, 2016, Journal of Hematology & Oncology.

Comparison of outcomes of HCT in blast phase of BCR-ABL1- MPN with de novo AML and with AML following MDS.

Y. Liu, M. Aljurf, J. Szer, 2020, Blood advances.

Trends in the use of hematopoietic stem cell transplantation for adults with acute lymphoblastic leukemia in Europe: a report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

J. Esteve, F. Baron, S. Wetten, 2019, Annals of Hematology.

Impact of risk score calculations in choosing front‐line tyrosine kinase inhibitors for patients with newly diagnosed chronic myeloid leukemia in the chronic phase

B. Savani, Bei Hu, 2014, European journal of haematology.

Extramedullary relapses after allogeneic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome

A. Barrett, B. Savani, S. Strickland, 2010, Haematologica.

The Level of Minimal Residual Disease in Primitive Progenitor Cells from CML Patients after Allogeneic Stem Cell Transplantation Is Higher Than after Treatment with Tyrosine Kinase Inhibitors.

K. Rezvani, K. Keyvanfar, A. Barrett, 2008 .

Improved Outcomes of Haploidentical Hematopoietic Cell Transplantation with Total Body Irradiation-Based Myeloablative Conditioning in Acute Lymphoblastic Leukemia.

M. Labopin, A. Nagler, M. Mohty, 2021, Transplantation and cellular therapy.

Impact of total body irradiation‐ vs chemotherapy‐based myeloablative conditioning on outcomes of haploidentical hematopoietic cell transplantation for acute myelogenous leukemia

M. Labopin, D. Blaise, A. Nagler, 2020, American journal of hematology.

Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

J. Esteve, F. Baron, M. Labopin, 2017, Haematologica.

Extracorporeal photopheresis versus anticytokine therapy as a second-line treatment for steroid-refractory acute GVHD: a multicenter comparative analysis.

M. Robin, N. Russell, H. Greinix, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced intensity conditioning allogeneic hematopoietic cell transplantation for adult acute myeloid leukemia in complete remission - a review from the Acute Leukemia Working Party of the EBMT

D. Blaise, A. Nagler, M. Mohty, 2015, Haematologica.

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Developing Recommendations to Improve Survivorship and Long-Term Outcomes.

S. Pavletic, S. Hashmi, N. Majhail, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of FLAMSA-based reduced intensity conditioning with treosulfan/fludarabine conditioning for patients with acute myeloid leukemia: an ALWP/EBMT analysis

A. Ganser, M. Labopin, A. Nagler, 2018, Bone Marrow Transplantation.

Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells from unrelated donors, a Center for International Blood and Marrow Transplant Research analysis.

J. Wingard, B. Shaw, H. Lazarus, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Personalizing rabbit anti-thymocyte globulin therapy for prevention of graft-versus-host disease after allogeneic hematopoietic cell transplantation: is there an optimal dose?

A. Nagler, M. Mohty, B. Savani, 2019, Bone Marrow Transplantation.

The effects of bortezomib on bone disease in patients with multiple myeloma

M. Mohty, P. Moreau, E. Terpos, 2014, Cancer.

Current Status and Perspectives of Irradiation-Based Conditioning Regimens for Patients with Acute Leukemia Undergoing Hematopoietic Stem Cell Transplantation

A. Nagler, B. Savani, G. Váradi, 2019, Clinical hematology international.

Underdiagnosed veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) as a major cause of multi-organ failure in acute leukemia transplant patients: an analysis from the EBMT Acute Leukemia Working Party

F. Baron, M. Labopin, A. Nagler, 2020, Bone Marrow Transplantation.

Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a position statement from an international expert group

P. Richardson, F. Baron, I. Yakoub-Agha, 2019, Bone Marrow Transplantation.

Preparative regimen dosing for hematopoietic stem cell transplantation in patients with chronic hepatic impairment: analysis of the literature and recommendations.

B. Savani, K. Culos, M. Bodge, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

How can we reduce hepatic veno-occlusive disease-related deaths after allogeneic stem cell transplantation?

Douglas B. Johnson, B. Savani, 2012, Experimental hematology.

Genetic variation in donor CTLA-4 regulatory region is a strong predictor of outcome after allogeneic hematopoietic cell transplantation for hematologic malignancies.

D. Crawford, K. Brown-Gentry, Heidi Chen, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

J. Esteve, F. Baron, M. Labopin, 2017, Haematologica.

The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation

D. Blaise, A. Nagler, M. Mohty, 2018, Bone Marrow Transplantation.

Stem cell mobilization in lymphoma patients

M. Mohty, T. Ballinger, B. Savani, 2015 .

Allotransplantation for patients age ≥40 years with non-Hodgkin lymphoma: encouraging progression-free survival.

Alan M. Miller, R. Vij, M. Aljurf, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Personalizing Busulfan-Based Conditioning: Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee.

A. Paci, M. Perales, M. Mohty, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for

J. Esteve, H. Dombret, R. Foà, 2018, Bone Marrow Transplantation.

Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia.

K. Rezvani, A. Barrett, R. Childs, 2006, Blood.

Impact of Cytogenetic Risk on Outcomes of Non-T Cell Depleted Haploidentical Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia.

J. Esteve, R. Fanin, M. Labopin, 2022, Transplantation and cellular therapy.

Comparable outcomes of haploidentical transplant with TBF conditioning versus matched unrelated donor with fludarabine/busulfan conditioning for acute myeloid leukemia

N. Kröger, M. Labopin, I. Yakoub-Agha, 2020, Bone Marrow Transplantation.

Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation.

S. Crawford, P. Veys, R. Champlin, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Managing Endocrine Disorders in Adults After Hematopoietic Stem Cell Transplantation

B. Savani, Juliana Matthews, Leslee N Matheny, 2019, Clinical hematology international.

Characteristics of Graft-versus-Host Disease (GvHD) after Post-transplant Cyclophosphamide versus Conventional GvHD Prophylaxis.

M. Perales, J. Pidala, C. Abboud, 2022, Transplantation and cellular therapy.

Total body irradiation plus fludarabine versus thiotepa, busulfan plus fludarabine as a myeloablative conditioning for adults with acute lymphoblastic leukemia treated with haploidentical hematopoietic cell transplantation. A study by the Acute Leukemia Working Party of the EBMT

M. Labopin, A. Nagler, M. Mohty, 2022, Bone Marrow Transplantation.

Comparable Long-Term Outcome after Allogeneic Stem-Cell Transplantation from Sibling and Matched Unrelated Donors in AML Patients Older than 50 years. A Report on Behalf of the ALWP of EBMT.

A. Ganser, M. Labopin, D. Blaise, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party

M. Labopin, I. Yakoub-Agha, D. Blaise, 2017, Journal of Hematology & Oncology.

Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia: No Impact of Pre-transplant Extramedullary Disease on Outcome

M. Tallman, R. Gale, T. Shea, 2015, Bone Marrow Transplantation.

Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell lymphoma: a cohort analysis from the center for international blood and marrow transplant research.

P. Hari, R. Gale, M. Cairo, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT

J. Esteve, F. Baron, M. Labopin, 2019, Haematologica.

Single- or double-unit UCBT following RIC in adults with AL: a report from Eurocord, the ALWP and the CTIWP of the EBMT

F. Baron, M. Labopin, P. Chevallier, 2017, Journal of Hematology & Oncology.

HLA DR15 antigen status does not impact graft-versus-host disease or survival in HLA-matched sibling transplantation for hematologic malignancies.

M. Aljurf, B. George, M. Flowers, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: A report from the acute leukemia working party of the EBMT

J. Esteve, C. Craddock, F. Baron, 2017, American journal of hematology.

Favorable outcomes in patients surviving 5 or more years after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.

A. Barrett, M. Bevans, S. Mitchell, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases

Michael J. Eckrich, W. Wood, Zhezhen Jin, 2017, Haematologica.

Does peritransplantation use of rituximab reduce the risk of EBV reactivation and PTLPD?

P. Pohlmann, A. Kassim, J. Greer, 2009, Blood.

Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34+ Yields Are Less.

J. Szer, D. Stroncek, J. Liesveld, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Predictive Factors for Outcome of First Allogeneic Transplant for Elderly Patients With Acute Lymphoblastic Leukemia.

H. Einsele, R. Fanin, N. Kröger, 2021, Clinical lymphoma, myeloma & leukemia.

Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT

J. Esteve, A. Ganser, F. Baron, 2016, Haematologica.

Avascular necrosis of bone after allogeneic hematopoietic cell transplantation in children and adolescents.

W. Wood, M. Sorror, H. Lazarus, 2014, Biology of Blood and Marrow Transplantation.

Defining Incidence and Risk Factors for Catheter-Associated Bloodstream Infections in an Outpatient Adult Hematopoietic Cell Transplantation Program.

Heidi Chen, A. Kassim, B. Savani, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Improving the Odds.

E. Copelan, B. Savani, M. Byrne, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Peripheral blood progenitor cell mobilization for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation.

M. Perales, M. Mohty, J. Wingard, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT

H. Greinix, Z. DeFilipp, D. Kelly, 2018, Bone Marrow Transplantation.

Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell Transplantation.

M. Norkin, M. Aljurf, J. Wingard, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia

F. Baron, M. Labopin, P. Chevallier, 2021, Journal of Hematology & Oncology.

Umbilical cord blood transplant: expanding the options

B. Savani, S. Sengsayadeth, 2013, Expert review of hematology.

Pretransplant vaccinations in allogeneic stem cell transplantation donors and recipients: an often-missed opportunity for immunoprotection?

P. Ljungman, J. Styczyński, B. Savani, 2015, Bone Marrow Transplantation.

Comparison of Haploidentical Bone Marrow versus Matched Unrelated Donor Peripheral Blood Stem Cell Transplantation with Posttransplant Cyclophosphamide in Patients with Acute Leukemia

N. Kröger, M. Labopin, A. Nagler, 2020, Clinical Cancer Research.

Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis.

M. Norkin, A. Barrett, M. Boeckh, 2016, Blood.

Minimal residual disease in myeloma: are we there yet?

Annette S. Kim, A. Kassim, C. Mosse, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

When should we tell patients there may be no blood? Evaluating the ‘informed’ consent process

E. Gehrie, B. Savani, Garrett S. Booth, 2022, British journal of haematology.

Taking a BiTE out of the CAR T space race

O. Oluwole, B. Savani, B. Dholaria, 2021, British journal of haematology.

Spiritual Well-Being in Hispanic and Non-Hispanic Survivors of Allogeneic Hematopoietic Stem Cell Transplantation

Li Yang, L. Wehrlen, M. Bevans, 2015, Journal of psychosocial oncology.

ASBMT Statement on Routine Prophylaxis for Central Nervous System Recurrence of Acute Lymphoblastic Leukemia following Allogeneic Hematopoietic Cell Transplantation.

M. Perales, A. Nagler, Z. DeFilipp, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The outcome of two or more HLA loci mismatched unrelated donor hematopoietic cell transplantation for acute leukemia: an ALWP of the EBMT study

M. Labopin, A. Nagler, M. Mohty, 2020, Bone Marrow Transplantation.

Allogeneic haematopoietic cell transplantation for extranodal natural killer/T‐cell lymphoma, nasal type: a CIBMTR analysis

Sonali M. Smith, M. Perales, E. Jacobsen, 2018, British journal of haematology.

Conditioning regimens for allogeneic hematopoietic stem cell transplants in acute myeloid leukemia

A. Nagler, M. Mohty, A. Bacigalupo, 2017, Bone Marrow Transplantation.

Outcomes after use of two standard ablative regimens in patients with refractory acute myeloid leukaemia: a retrospective, multicentre, registry analysis.

M. Labopin, A. Nagler, M. Mohty, 2015, The Lancet. Haematology.

Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation.

A. Barrett, N. Hensel, V. Ghetie, 2005, Blood.

Impact of donor kinship on non-T-cell depleted haploidentical stem cell transplantation with post transplantation cyclophosphamide for acute leukemia: From the ALWP of the EBMT

M. Labopin, D. Blaise, A. Nagler, 2022, Bone Marrow Transplantation.

Shorter Interdonation Interval Contributes to Lower Cell Counts in Subsequent Stem Cell Donations.

D. Stroncek, B. Shaw, G. Switzer, 2021, Transplantation and cellular therapy.

Role of allo-SCT for CML in 2010

N. Venepalli, S. Mielke, B. Savani, 2010, Bone Marrow Transplantation.

Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EBMT

N. Kröger, M. Labopin, A. Nagler, 2021, Journal of Hematology & Oncology.

Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT

M. Labopin, D. Blaise, A. Nagler, 2020, Journal of Hematology & Oncology.

Collection of Peripheral Blood Progenitor Cells in One Day is Associated with Decreased Donor Toxicity compared to Two Days in Unrelated Donors.

J. Wingard, J. Liesveld, T. Spitzer, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Randomized Double-Blind Study of the Safety and Immunogenicity of Standard-Dose Trivalent Inactivated Influenza Vaccine versus High-Dose Trivalent Inactivated Influenza Vaccine in Adult Hematopoietic Stem Cell Transplantation Patients.

C. Fonnesbeck, A. Kassim, N. Halasa, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

‘To treat or not to treat’: raising awareness on the effects of graft versus host disease drugs on musculoskeletal system

M. Aljurf, S. Hashmi, B. Savani, 2018, Bone Marrow Transplantation.

Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation

M. Abecassis, P. Richardson, F. Baron, 2016, Bone Marrow Transplantation.

Is there any role for physical therapy in chronic GvHD?

A. El-Jawahri, A. Cheville, S. Hashmi, 2018, Bone Marrow Transplantation.

Time to consider HPV vaccination after allogeneic stem cell transplantation.

A. Barrett, Stephanie J. Lee, C. Anasetti, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clinical management of genital chronic GvHD

P. Stratton, B. Hamilton, N. Majhail, 2017, Bone Marrow Transplantation.

Blood and Marrow Transplantation Long Term Management: Prevention and Complications

B. Savani, 2013 .

Kahn JM, Brazauskas R, Tecca HR, et al. Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases. Blood Adv. 2020;4(9):2084-2094.

M. Norkin, B. George, R. Gale, 2020, Blood advances.

Predictors of lost to follow-up among pediatric and adult hematopoietic cell transplant survivors: A report from the Center for International Blood and Marrow Transplant Research.

W. Wood, M. Aljurf, A. Yoshimi, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

ASBMT Practice Guidelines Committee Survey on Long-Term Follow-Up Clinics for Hematopoietic Cell Transplant Survivors.

M. Perales, A. Nagler, M. Mohty, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcomes of Allogeneic Hematopoietic Cell Transplantation in Children and Young Adults with Chronic Myeloid Leukemia: A CIBMTR Cohort Analysis.

W. Wood, R. Sparapani, R. Gale, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Lost in transition: the essential need for long-term follow-up clinic for blood and marrow transplantation survivors.

A. Tichelli, S. Hashmi, B. Savani, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prolonged chronic graft-versus-host disease is a risk factor for thyroid failure in long-term survivors after matched sibling donor stem cell transplantation for hematologic malignancies.

A. Barrett, B. Savani, S. Goodman, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Male survivors of allogeneic hematopoietic stem cell transplantation have a long term persisting risk of cardiovascular events.

C. Hourigan, A. Barrett, S. Shanbhag, 2014, Experimental hematology.

transplantation How I treat late effects in adults after allogeneic stem cell

Stephanie J. Lee, B. Savani, S. Jagasia, 2014 .

How I treat late effects in adults after allogeneic stem cell transplantation.

Stephanie J. Lee, B. Savani, S. Jagasia, 2011, Blood.

Recovery of spermatogenesis after total-body irradiation.

A. Barrett, B. Savani, A. Shenoy, 2006, Blood.

Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with FLT3-internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

J. Esteve, H. Döhner, F. Baron, 2020, Haematologica.

The impact of anti-thymocyte globulin on the outcomes of Patients with AML with or without measurable residual disease at the time of allogeneic hematopoietic cell transplantation

J. Esteve, J. Bourhis, M. Labopin, 2019, Leukemia.

Reduced Relapse Incidence with FLAMSA-RIC Compared with Busulfan/Fludarabine for Acute Myelogenous Leukemia Patients in First or Second Complete Remission: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

G. Mufti, M. Labopin, D. Blaise, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report.

J. Wingard, J. Gea-Banacloche, S. Paczesny, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR® analysis

Allen R. Chen, M. Boeckh, M. Aljurf, 2015, Bone Marrow Transplantation.

Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation

J. Esteve, F. Baron, M. Labopin, 2020, Bone Marrow Transplantation.

Outcomes after autologous hematopoietic cell transplantation in POEMS syndrome and comparison with multiple myeloma

A. Dispenzieri, Shaji K. Kumar, M. Qazilbash, 2022, Blood advances.

BACTERIAL BLOOD STREAM INFECTIONS (BSI), PARTICULARLY POST-ENGRAFTMENT BSI, ARE ASSOCIATED WITH INCREASED MORTALITY AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

G. Papanicolaou, V. Brown, M. Aljurf, 2018, Bone Marrow Transplantation.

Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy.

M. Bar, J. Wagner, J. Sierra, 2021, Transplantation and cellular therapy.

Correction: The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation

D. Blaise, A. Nagler, M. Mohty, 2018, Bone Marrow Transplantation.

Common non-seasonal viral infections after hematopoietic stem cell transplantation

M. Mohty, B. Savani, Bei Hu, 2013 .

Graft‐versus‐host disease and graft‐versus‐leukaemia effects in secondary acute myeloid leukaemia: a retrospective, multicentre registry analysis from the Acute Leukaemia Working Party of the EBMT

N. Kröger, F. Baron, M. Labopin, 2019, British journal of haematology.

Pulmonary function following total body irradiation (with or without lung shielding) and allogeneic peripheral blood stem cell transplant

N. Simone, H. Ning, A. Barrett, 2007, Bone Marrow Transplantation.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report.

Anita Lawitschka, Stephanie J. Lee, K. Syrjala, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Securing the graft during pandemic: are we ready for cryopreservation for all?

A. Artz, B. Savani, B. Dholaria, 2020, Biology of Blood and Marrow Transplantation.

How do we plan hematopoietic cell transplant and cellular therapy with the looming COVID‐19 threat?

B. Savani, B. Dholaria, Bhagirathbhai R. Dholaria, 2020, British journal of haematology.

Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia

M. Krem, C. Hourigan, M. Aljurf, 2021, Blood advances.

Bone marrow versus mobilized peripheral blood stem cell graft in T-cell-replete haploidentical transplantation in acute lymphoblastic leukemia

M. Labopin, D. Blaise, A. Nagler, 2020, Leukemia.

Increased risk of cervical dysplasia in long-term survivors of allogeneic stem cell transplantation--implications for screening and HPV vaccination.

A. Barrett, P. Stratton, B. Savani, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T Cell and NK/T Cell Lymphomas: An International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.

R. Advani, A. Nademanee, J. Friedberg, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Immune-Mediated Complications after Hematopoietic Stem Cell Transplantation.

M. Mohty, B. Shaw, S. Rubinstein, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

CAR T cell therapy in solid tumors: A review of current clinical trials

O. Oluwole, B. Savani, B. Dholaria, 2021, EJHaem.

New indications and platforms for CAR‐T therapy in lymphomas beyond DLBCL

B. Savani, M. Hamadani, M. Iqbal, 2021, EJHaem.

Promise and pitfalls of allogeneic chimeric antigen receptor therapy in plasma cell and lymphoid malignancies

B. Savani, M. Hamadani, S. Chhabra, 2021, British journal of haematology.

Examining disease boundaries: Genetics of myelodysplastic/myeloproliferative neoplasms

B. Savani, T. Jain, Michael J. Hochman, 2021, EJHaem.

Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning.

M. Sorror, J. Wingard, U. Popat, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Repeated PR1 and WT1 peptide vaccination in Montanide-adjuvant fails to induce sustained high-avidity, epitope-specific CD8+ T cells in myeloid malignancies

K. Rezvani, A. Barrett, S. Mielke, 2011, Haematologica.

Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015

M. Norkin, W. Wood, J. Wingard, 2015, Bone Marrow Transplantation.

Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission.

Alan M. Miller, R. Vij, F. Baron, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Lamivudine prophylaxis and hepatitis B vaccination for prevention of hepatitis B virus reverse seroconversion in long-term survivors after allogeneic stem cell transplantation.

R. Childs, B. Savani, A. Shenoy, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Skin, Hair and Musculoskeletal Complications

B. Savani, F. Ayuk, 2018, The EBMT Handbook.

Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers

C. Vnencak-Jones, A. Kassim, J. Greer, 2012, Bone Marrow Transplantation.

Long‐term outcome after a treosulfan‐based conditioning regimen for patients with acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

M. Labopin, A. Nagler, M. Mohty, 2017, Cancer.

Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome–positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transpl

J. Esteve, F. Baron, A. Nagler, 2016, Cancer.

Prognostic scoring system after transplantation in myeloma: predicting early relapse

B. Savani, M. Beksaç, 2020, British journal of haematology.

Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the American Society for Blood and Marrow Transplantation.

R. Vij, P. Hari, M. Perales, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research

R. Vij, B. Sandmaier, M. Aljurf, 2019, Haematologica.

S. Hashmi, M. Litzow, B. Savani, 2016, World journal of stem cells.

Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia

Marcela R. Uribe, R. Srinivasan, K. Rezvani, 2007, Leukemia.

Early Th1 immunity promotes immune tolerance and may impair graft-versus-leukemia effect after allogeneic hematopoietic cell transplantation

J. Crowe, M. Rock, S. Yoder, 2016, Haematologica.

Programmed death-1 immune checkpoint blockade in the treatment of hematological malignancies

A. Nagler, B. Savani, P. Tsirigotis, 2016, Annals of medicine.

Febrile Neutropenia in Patients with Acute Leukemia with Long-Term Central Venous Access in Kuwait: Microbial Spectrum, Outcome and Catheter Management

B. Savani, R. Pandita, S. al Bahar, 2000, Medical Principles and Practice.

Impact of Donor Type in Patients with AML Given Allogeneic Hematopoietic Cell Transplantation After Low-Dose TBI-Based Regimen

F. Baron, M. Labopin, D. Blaise, 2018, Clinical Cancer Research.

Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis.

Sonali M. Smith, P. Hari, P. Armand, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT

M. Labopin, A. Nagler, M. Mohty, 2016, Journal of Hematology & Oncology.

Acute renal failure after intravenous anti‐D immune globulin in an adult with immune thrombocytopenic purpura

M. Taplin, B. Savani, R. Seder, 2003, American journal of hematology.

Clinical guide to ABO-incompatible allogeneic stem cell transplantation.

E. Gehrie, B. Savani, Garrett S. Booth, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A Prognostic Model Predicting Autologous Transplantation Outcomes in Children, Adolescents and Young Adults with Hodgkin Lymphoma

J. Vose, Sonali M. Smith, W. Wood, 2015, Bone Marrow Transplantation.

Granulocyte Colony-Stimulating Factor Potentiated Severe Atypical Vincristine-Induced Neuropathy

B. Savani, R. Pandita, S. Al-Bahar, 1998, Medical Principles and Practice.

Understanding and managing large B cell lymphoma relapses after CAR T cell therapy.

O. Oluwole, B. Hill, N. Majhail, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

CAR T-cell therapy for the management of refractory/relapsed high-grade B-cell lymphoma: a practical overview

M. Perales, I. Yakoub-Agha, A. Nagler, 2020, Bone Marrow Transplantation.

Epigenetic landscape of the TERT promoter: a potential biomarker for high risk AML/MDS

B. Dumitriu, K. Rezvani, Xingmin Feng, 2016, British journal of haematology.

Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.

Tao Wang, Thomas Spitzer, Daniel J Weisdorf, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow Transplantation (EBMT)

M. Abecassis, P. Richardson, F. Baron, 2015, Bone Marrow Transplantation.

Country-Level Macroeconomic Indicators Predict Early Post-Allogeneic Hematopoietic Cell Transplantation Survival in Acute Lymphoblastic Leukemia: A CIBMTR Analysis.

W. Wood, K. Sullivan, M. Aljurf, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study.

Alan M. Miller, P. D. Dal Cin, J. Sierra, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Survival Trends in Infants Undergoing Allogeneic Hematopoietic Cell Transplant

M. Pasquini, B. George, R. Gale, 2019, JAMA pediatrics.

Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

H. Einsele, N. Kröger, M. Labopin, 2019, Journal of Hematology & Oncology.

Post‐transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA‐identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow T

M. Labopin, P. Chevallier, D. Blaise, 2020, Cancer.

RIC versus MAC UCBT in adults with AML: A report from Eurocord, the ALWP and the CTIWP of the EBMT

J. Esteve, J. Sierra, F. Baron, 2016, Oncotarget.

High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT.

K. Rezvani, K. Keyvanfar, A. Barrett, 2006, Blood.

Transplantation in AML CR1.

B. Savani, 2010, Blood.

Impact of ABO incompatibility on patients’ outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the Acute Leukemia Working Party of the EBMT

M. Labopin, D. Blaise, A. Nagler, 2017, Haematologica.

Can we modify transplant outcome by improving lymphocyte recovery?

B. Savani, 2011, Cytotherapy.

Non-infectious pulmonary toxicity after allogeneic hematopoietic cell transplantation.

M. Sorror, M. Krem, M. Pasquini, 2022, Transplantation and cellular therapy.

Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T cell-depleted allogeneic stem cell transplantation.

K. Rezvani, A. Barrett, R. Childs, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pure red blood cell aplasia: patient management pitfalls in major ABO‐incompatible haematopoietic cell transplantation

A. Langston, B. Savani, G. Booth, 2021, British journal of haematology.

Older patients with myeloma derive similar benefit from autologous transplantation.

A. Krishnan, S. Lonial, P. Hari, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Low CD34 dose is associated with poor survival after reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndrome.

M. Perales, O. Ringdén, H. Lazarus, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Efficacy of CD34+ stem cell dose in patients undergoing allogeneic peripheral blood stem cell transplantation after total body irradiation.

P. Albert, A. Barrett, B. Savani, 2007, Biology of Blood and Marrow Transplantation.

Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation.

R. Vij, M. Aljurf, R. Gale, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT

J. Esteve, F. Baron, A. Nagler, 2016, Bone Marrow Transplantation.

Lymphodepletion is permissive to the development of spontaneous T-cell responses to the self-antigen PR1 early after allogeneic stem cell transplantation and in patients with acute myeloid leukemia undergoing WT1 peptide vaccination following chemotherapy

K. Rezvani, R. Childs, S. Mielke, 2012, Cancer Immunology, Immunotherapy.

Lineage‐specific engraftment and outcomes after T‐cell‐depleted peripheral blood stem cell transplant with Flu/Cy/TBI conditioning

R. Childs, E. Read, S. Leitman, 2005, British journal of haematology.

Haematopoietic progenitor cell transplantation in adults with symptomatic sickle cell disease: the time has arrived

M. Cairo, B. Savani, 2021, British journal of haematology.

Selectively T cell-depleted allografts from HLA-matched sibling donors followed by low-dose posttransplantation immunosuppression to improve transplantation outcome in patients with hematologic malignancies.

A. Barrett, D. Stroncek, R. Childs, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor age determines outcome in acute leukemia patients over 40 undergoing haploidentical hematopoietic cell transplantation

M. Labopin, D. Blaise, A. Nagler, 2018, American journal of hematology.

Haploidentical transplantation: selecting optimal conditioning regimen and stem cell source.

D. Blaise, M. Mohty, B. Savani, 2016, Seminars in hematology.

European Group for Blood and Marrow Transplantation Centers with FACT-JACIE Accreditation Have Significantly Better Compliance with Related Donor Care Standards.

M. Norkin, B. Shaw, G. Switzer, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

T-cell depleted peripheral blood stem cell allotransplantation with T-cell add-back for patients with hematological malignancies: effect of chronic GVHD on outcome.

K. Rezvani, A. Barrett, R. Childs, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection Centers.

J. Wingard, D. Stroncek, J. Liesveld, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic stem cell transplantation with unrelated cord blood or haploidentical donor grafts in adult patients with secondary acute myeloid leukemia, a comparative study from Eurocord and the ALWP EBMT

F. Baron, M. Labopin, P. Chevallier, 2019, Bone Marrow Transplantation.

Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States.

W. Wood, M. Sorror, F. Baron, 2017, Blood.

Understanding basic steps to hematopoietic stem cell transplantation evaluation.

B. Savani, M. Logue, 2013, American journal of blood research.

Composite GRFS and CRFS Outcomes After Adult Alternative Donor HCT.

M. Aljurf, R. Gale, J. Pidala, 2020, Journal of Clinical Oncology.

GVHD after umbilical cord blood transplantation for acute leukemia: an analysis of risk factors and effect on outcomes

M. Aljurf, I. Lewis, R. Gale, 2016, Bone Marrow Transplantation.

Leukemia Surveillance Counterpoint: USA

O. Oluwole, B. Savani, N. Reddy, 2013 .

Validation of International Chronic Ocular Graft-Versus-Host Disease (GVHD) Group Diagnostic Criteria as a Chronic Ocular GVHD-Specific Metric

T. Koyama, A. Kassim, B. Savani, 2017, Cornea.

Outcomes of allogeneic haematopoietic cell transplantation for chronic neutrophilic leukaemia: A combined CIBMTR/CMWP of EBMT analysis

I. Yakoub-Agha, D. Mclornan, A. Radujkovic, 2022, British journal of haematology.

Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donors

M. Labopin, D. Blaise, A. Nagler, 2020, Journal of Hematology & Oncology.

Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT

A. Ganser, C. Craddock, M. Labopin, 2020, Bone Marrow Transplantation.

M. Perales, F. Appelbaum, J. Pidala, 2014, Haematologica.

Summary of Scientific and Statistical Methods, Study Endpoints and Definitions for Observational and Registry-Based Studies in Hematopoietic Cell Transplantation

A. Nagler, B. Savani, A. Kanate, 2019, Clinical hematology international.

Systematic Nutritional Support in Allogeneic Hematopoietic Stem Cell Transplant Recipients.

H. Einsele, B. Savani, S. Fuji, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

fficacy of CD 34 Stem Cell Dose in Patients ndergoing Allogeneic Peripheral Blood Stem Cell ransplantation after Total Body Irradiation

P. Albert, A. Barrett, B. Savani, 2007 .

Stem cell transplantation with reduced-intensity conditioning regimens: a review of ten years experience with new transplant concepts and new therapeutic agents

A. Barrett, B. Savani, A. Barrett, 2006, Leukemia.

Chronic GVHD and pretransplantation abnormalities in pulmonary function are the main determinants predicting worsening pulmonary function in long-term survivors after stem cell transplantation.

R. Srinivasan, K. Rezvani, A. Barrett, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of antithymocyte globulin on outcomes of allogeneic hematopoietic cell transplantation with TBI.

J. Bourhis, M. Labopin, A. Nagler, 2019, Blood advances.

Risk factors associated with early viral reactivation following haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide: a pilot study

A. Kassim, B. Savani, M. Jagasia, 2020, Annals of Hematology.

Who is the best relative? Optimizing haploidentical donor transplantation in lymphoma

B. Savani, A. Kanate, 2020, British journal of haematology.

Haploidentical transplantation outcomes for secondary acute myeloid leukemia: Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) study

M. Labopin, D. Blaise, A. Nagler, 2018, American journal of hematology.

Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP).

Heidi Chen, A. Kassim, J. Greer, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Extracorporeal photopheresis as second-line treatment for acute graft-versus-host disease: impact on six-month freedom from treatment failure

N. Russell, H. Greinix, A. Kassim, 2014, Haematologica.

Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia

J. Esteve, F. Baron, M. Labopin, 2021, Bone Marrow Transplantation.

Hematopoietic Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Updated 2019 Evidence-Based Review from the American Society for Transplantation and Cellular Therapy.

R. Larson, M. Perales, A. Nagler, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia – a matched pair analysis by the Acute Leukaemia Working Party of EBMT

J. Esteve, F. Baron, M. Labopin, 2018, British journal of haematology.

Post-remission strategies for the prevention of relapse following allogeneic hematopoietic cell transplantation for high-risk acute myeloid leukemia: expert review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

J. Esteve, F. Baron, M. Labopin, 2018, Bone Marrow Transplantation.

Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: Impact of tyrosine kinase inhibitor and minimal residual disease

M. Norkin, R. Vij, M. Aljurf, 2013, Leukemia.

Conditioning regimens in allo-SCT for thalassemia major

V. Mathews, B. Savani, 2014, Bone Marrow Transplantation.

Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoietic Cell Transplant Reveals Improved Survival for Young Patients in Recent Years

J. Esteve, M. Labopin, D. Blaise, 2020, Clinical Cancer Research.

Response to "What is the optimal approach to major ABO-incompatible allogeneic stem cell transplantation".

E. Gehrie, B. Savani, G. Booth, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-term Survival and Late Effects among 1-year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic Syndromes

Zhiwei, Saber, M. Norkin, 2014 .

Plerixafor in AL amyloidosis: improved graft composition and faster lymphocyte recovery after auto-SCT in patient with end-stage renal-disease

B. Savani, M. Jagasia, D. Dunn, 2012, Bone Marrow Transplantation.

Preventing Measles among Immunosuppressed Cancer and Hematopoietic Cell Transplant Patients: A Position Statement by the American Society for Transplantation and Cellular Therapy.

M. Kamboj, J. Englund, S. Pergam, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prophylactic intravenous immunoglobulin does not have a role in hematopoietic stem-cell transplantation: is the evidence clear?

B. Savani, S. Goodman, N. Reddy, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Engraftment and graft failure: Assessment and practical considerations

B. Savani, M. Jagasia, Y. Jethava, 2017 .

Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia.

A. Gennery, M. Aljurf, B. George, 2019, Blood advances.

When Can You Discard Stem Cells?

B. Shaw, E. Gehrie, B. Savani, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Salvage second hematopoietic cell transplantation in myeloma.

J. Vose, A. Krishnan, S. Lonial, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in high-risk patients.

K. Rezvani, A. Barrett, B. Savani, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-term impact of prior rituximab therapy and early lymphocyte recovery on auto-SCT outcome for diffuse large B-cell lymphoma

Y. Shyr, B. Savani, D. Stover, 2012, Bone Marrow Transplantation.

Early lymphocyte reconstitution is associated with improved transplant outcome after cord blood transplantation.

A. Kassim, H. Frangoul, J. Greer, 2011, Cytotherapy.

The Concentration of Total Nucleated Cells in Harvested Bone Marrow for Transplantation Has Decreased over Time.

M. Norkin, J. Szer, J. Liesveld, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation.

R. Vij, M. Aljurf, R. Gale, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Optimizing Antithymocyte Globulin Dosing for Unrelated Donor Allogeneic Hematopoietic Cell Transplantation Based on Recipient Absolute Lymphocyte Count.

Heidi Chen, A. Kassim, J. Greer, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Next-generation long-term transplant clinics: improving resource utilization and the quality of care through health information technology

J. Warner, B. Savani, M. Jagasia, 2016, Bone Marrow Transplantation.

Significant Improvements in the Practice Patterns of Adult Related Donor Care in US Transplantation Centers.

M. Norkin, J. Liesveld, Z. DeFilipp, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT

M. Norkin, W. Wood, J. Snowden, 2016, Bone Marrow Transplantation.

Advances in gene therapy for hematologic disease and considerations for transfusion medicine.

Opal L. Reddy, D. Stroncek, B. Savani, 2020, Seminars in hematology.

Harmonization of Busulfan Plasma Exposure Unit (BPEU): A Community-Initiated Consensus Statement.

A. Paci, M. Perales, V. Seewaldt, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Complementary and alternative medicine in HSCT

Ibrahim N. Muhsen, S. Hashmi, B. Savani, 2021, Blood and Marrow Transplantation Long Term Management.

Long-term follow-up of informal caregivers after allo-SCT: a systematic review

E. Wulff-Burchfield, B. Savani, M. Jagasia, 2013, Bone Marrow Transplantation.

Overview of approved CAR‐T therapies, ongoing clinical trials, and its impact on clinical practice

O. Oluwole, B. Savani, B. Dholaria, 2021, EJHaem.

Feasibility of outpatient administration of axicabtagene ciloleucel and brexucabtagene autoleucel using telemedicine tools: The Vanderbilt experience

R. Jayani, A. Kassim, O. Oluwole, 2022, British journal of haematology.

Chimeric antigen receptor‐T cell therapies: The changing landscape

O. Oluwole, B. Savani, B. Dholaria, 2021, EJHaem.

J. Warner, Heidi Chen, A. Kassim, 2021, Journal of hematology.

High prevalence of obesity in acute promyelocytic leukemia (APL): implications for differentiating agents in APL and metabolic syndrome

D. Head, B. Savani, N. Reddy, 2011, Therapeutic advances in hematology.

Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation.

M. Norkin, M. Boeckh, M. Aljurf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Maintenance Therapies for Hodgkin and Non-Hodgkin Lymphomas After Autologous Transplantation: A Consensus Project of ASBMT, CIBMTR, and the Lymphoma Working Party of EBMT

J. Vose, S. Montoto, Sonali M. Smith, 2019, JAMA oncology.

Posttransplant maintenance therapy in multiple myeloma: the changing landscape

M. Mohty, L. Garderet, B. Savani, 2017, Blood Cancer Journal.

Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia.

J. Cortes, M. Aljurf, M. Tallman, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.

J. Gribben, E. Montserrat, F. Awan, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-term outcome after autologous or allogeneic stem cell transplantation in patients with recurrent follicular lymphoma

O. Oluwole, J. Greer, B. Savani, 2012, Bone Marrow Transplantation.

Genetic variation in recipient B-cell activating factor modulates phenotype of GVHD.

D. Crawford, K. Brown-Gentry, Heidi Chen, 2011, Blood.

Lower Genital Tract Precancer and Cancer in Hematopoietic Cell Transplant Survivors and the Role of HPV: A Systematic Review and Future Perspectives

M. Aljurf, S. Hashmi, B. Savani, 2019, Clinical hematology international.

Risks factors and timing of genital human papillomavirus (HPV) infection in female stem cell transplant survivors: a longitudinal study

A. Barrett, P. Stratton, M. Merideth, 2018, Bone Marrow Transplantation.

Improved outcome following allogeneic stem cell transplantation in chronic myeloid leukemia is associated with higher expression of BMI-1 and immune responses to BMI-1 protein

K. Rezvani, K. Keyvanfar, A. Barrett, 2010, Leukemia.

Treatment of relapsed blast-phase Philadelphia-chromosome-positive leukaemia after non-myeloablative stem-cell transplantation with donor lymphocytes and imatinib.

R. Srinivasan, K. Rezvani, A. Barrett, 2005, The Lancet. Oncology.

Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation.

J. Cortes, M. Aljurf, J. Szer, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.

J. Cortes, M. Aljurf, J. Szer, 2013, Blood.

Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report

J. Mehta, M. Perales, N. Saba, 2019, Clinical Cancer Research.

Immunomodulatory nonablative conditioning regimen for B-cell lymphoid malignancies.

A. Kassim, S. Brandt, D. Morgan, 2012, Experimental hematology.

Finding the best haematopoietic stem cell transplant regimen for GATA2 haploinsufficiency: how close are we?

B. Savani, J. Connelly, 2021, British journal of haematology.

Comprehensive Prognostication in Critically Ill Pediatric Hematopoietic Cell Transplant Patients: Results from Merging the Center for International Blood and Marrow Transplant Research (CIBMTR) and Virtual Pediatric Systems (VPS) Registries.

E. Guinan, M. Aljurf, M. Pasquini, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic stem cell transplantation and targeted therapy for FLT3/ITD+ acute myeloid leukemia: an update

M. Mohty, B. Savani, Praveen Vikas, 2014, Expert review of hematology.

Sequential standard dose mitoxantrone and cytosine arabinoside for newly diagnosed adult acute myeloblastic leukemia.

B. Savani, R. Pandita, S. al Bahar, 1999, Neoplasma.

Expanding transplant options to patients over 50 years. Improved outcome after reduced intensity conditioning mismatched-unrelated donor transplantation for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the EBMT

J. Esteve, N. Kröger, C. Craddock, 2016, Haematologica.

Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation.

J. Vose, S. Montoto, Sonali M. Smith, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long‐term outcomes among 2‐year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b‐cell lymphoma

W. Wood, Z. DeFilipp, B. Shaw, 2018, Cancer.

with TBI following cyclophosphamide in combination with busulfan compared Better leukemia-free and overall survival in AML in first remission

J. Cortes, M. Aljurf, J. Szer, 2013 .

Pretransplant pulmonary function tests predict risk of mortality following fractionated total body irradiation and allogeneic peripheral blood stem cell transplant.

R. Altemus, H. Ning, P. Guion, 2006, International journal of radiation oncology, biology, physics.

Expanded HCT-CI Definitions Capture Comorbidity Better for Younger Patients of Allogeneic HCT for Non-Malignant Diseases

M. Sorror, E. Guinan, M. Krem, 2022, Transplantation and Cellular Therapy.

Inferior Outcomes with Cyclosporine and Mycophenolate mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation.

M. Aljurf, R. Gale, J. Pidala, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Treosulphan versus busulphan: pros and cons

B. Savani, P. Patel, Michael T. Byrne, 2021, British journal of haematology.

Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT

M. Norkin, A. Nagler, J. Szer, 2018, Bone Marrow Transplantation.

Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantation.

J. Esteve, J. Bourhis, F. Baron, 2015, Blood.

Fludarabine and Busulfan versus Fludarabine, Cyclophosphamide, and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular Lymphoma.

Sonali M. Smith, P. Armand, S. Jaglowski, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registry.

S. Montoto, F. Baron, M. Perales, 2021, The Lancet. Haematology.

Relapsed or refractory large B‐cell lymphoma after chimeric antigen receptor T‐cell therapy: Current challenges and therapeutic options

R. Jayani, A. Kassim, O. Oluwole, 2023, British journal of haematology.

Roadmap for Starting an Outpatient Cellular Therapy Program

O. Oluwole, B. Savani, Katie S. Gatwood, 2022, Cancer Drug Discovery and Development.

ASTCT, CIBMTR and EBMT Clinical Practice recommendations for transplant and cellular therapies in mantle cell lymphoma.

Michael L. Wang, Sonali M. Smith, J. Friedberg, 2021, Bone Marrow Transplantation.

American Society of Transplantation and Cellular Therapy, Center of International Blood and Marrow Transplant Research, and European Society for Blood and Marrow Transplantation Clinical Practice Recommendations for Transplantation and Cellular Therapies in Mantle Cell Lymphoma

Michael L. Wang, Sonali M. Smith, J. Friedberg, 2021, Transplantation and cellular therapy.

Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysis.

Sonali M. Smith, Z. DeFilipp, H. Lazarus, 2018, Blood advances.

Expression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissues

M. Goswami, C. Hourigan, A. Barrett, 2014, Leukemia.

Impact of early CMV reactivation in cord blood stem cell recipients in the current era

M. Boeckh, J. Wingard, H. Lazarus, 2016, Bone Marrow Transplantation.

Autologous stem cell transplantation for adult acute leukemia in 2015: time to rethink? Present status and future prospects

M. Labopin, A. Nagler, M. Mohty, 2015, Bone Marrow Transplantation.

Efficacy and Pharmacoeconomic Impact of Letermovir for CMV Prophylaxis in Allogeneic Hematopoietic Cell Transplant Recipients

A. Kassim, B. Savani, M. Jagasia, 2019, Biology of Blood and Marrow Transplantation.

Diffuse large B‐cell lymphoma

B. Savani, M. Kharfan-Dabaja, A. Kanate, 2015 .

Second allogeneic haematopoietic cell transplantation using HLA‐matched unrelated versus T‐cell replete haploidentical donor and survival in relapsed acute myeloid leukaemia

A. Ganser, M. Labopin, P. Chevallier, 2021, British journal of haematology.

Chimeric antigen receptor T‐cell therapy: Challenges and framework of outpatient administration

O. Oluwole, B. Savani, B. Dholaria, 2021, EJHaem.

Graft‐versus‐host‐disease does not help acute lymphoblastic leukaemia patients with measurable residual disease

F. Baron, B. Savani, 2020, British journal of haematology.

Impact of Early Cytomegalovirus Reactivation in Cord Blood Stem Cell Recipients in the Current Era

Riches, M. Boeckh, H. Lazarus, 2016 .

Outcomes of rituximab‐BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation

M. Aljurf, R. Gale, L. Lekakis, 2020, Cancer.

The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen.

S. Montoto, Sonali M. Smith, J. Klein, 2015, Biology of Blood and Marrow Transplantation.

Machine learning and artificial intelligence in haematology

Arnon Nagler, Roni Shouval, Joshua A Fein, 2020, British journal of haematology.

Metabolic Complications Precede Alloreactivity and Are Characterized by Changes in Suppression of Tumorigenicity 2 Signaling.

D. K. Jung, A. Kassim, S. Paczesny, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Evolution of the donor T-cell repertoire in recipients in the second decade after allogeneic stem cell transplantation.

D. Douek, B. Hill, K. Keyvanfar, 2011, Blood.

Physicians Abstracts

J. Esteve, R. Unger, R. Unger, 2015, Bone Marrow Transplantation.

Introduction to long‐term survivorship after hematopoietic cell transplantation

A. Tichelli, B. Savani, 2021 .

How can we improve life expectancy and quality of life in long-term survivors after allogeneic stem cell transplantation?

B. Savani, 2012, Seminars in hematology.

The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia.

M. Norkin, B. Sandmaier, B. George, 2019, Blood advances.

Worldwide Network for Blood and Marrow Transplantation (WBMT) Recommendations Regarding Essential Medications Required To Establish An Early Stage Hematopoietic Cell Transplantation Program.

N. Kröger, M. Perales, M. Mohty, 2021, Transplantation and cellular therapy.

Is myeloablative dose intensity necessary in allogeneic hematopoietic cell transplantation for lymphomas?

B. Savani, M. Kharfan-Dabaja, A. Kanate, 2017, Bone Marrow Transplantation.

Improved survival after acute graft-versus-host disease diagnosis in the modern era

Alan M. Miller, R. Vij, W. Wood, 2017, Haematologica.

Risk Factors for Subsequent Central Nervous System Tumors in Pediatric Allogeneic Hematopoietic Cell Transplant: A Study from the Center for International Blood and Marrow Transplant Research (CIBMTR).

H. Sengeløv, Chi-kong Li, B. Shaw, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

F. Baron, M. Labopin, A. Nagler, 2019, Bone Marrow Transplantation.

Minimal residual disease negativity and lenalidomide maintenance therapy are associated with superior survival outcomes in multiple myeloma

A. Kassim, C. Mosse, R. Cornell, 2020, Bone Marrow Transplantation.

Allogeneic stem cell transplant in patients with acute myeloid leukemia and karnofsky performance status score less than or equal to 80%: A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation (EBMT)

J. Esteve, N. Kröger, M. Labopin, 2020, Cancer medicine.

Intravenous Busulfan Compared with Treosulfan-Based Conditioning for Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia: A Study on Behalf of the Acute Leukemia Working Party of European Society for Blood and Marrow Transplantation.

G. Mufti, M. Labopin, P. Chevallier, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Fludarabine or cyclophosphamide in combination with total body irradiation as myeloablative conditioning prior to allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the EBMT

J. Bourhis, M. Labopin, A. Nagler, 2023, Bone Marrow Transplantation.

Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia

N. Kröger, M. Labopin, I. Yakoub-Agha, 2022, Bone Marrow Transplantation.

Transplant outcomes for patients with therapy-related acute myeloid leukemia with prior lymphoid malignancy: an ALWP of EBMT study

A. Ganser, M. Labopin, P. Chevallier, 2019, Bone Marrow Transplantation.

Impact of measurable residual disease on outcomes of unrelated donor haematopoietic cell transplantation with post‐transplant cyclophosphamide in AML in first complete remission

M. Labopin, I. Yakoub-Agha, D. Blaise, 2023, British journal of haematology.

Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT

J. Esteve, N. Kröger, M. Labopin, 2021, Bone Marrow Transplantation.

Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma.

A. Krishnan, S. Lonial, P. Hari, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Relapse and survival after transplantation for complex karyotype acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and the University of Texas MD Anderson Cancer Center

J. Esteve, M. Labopin, P. Chevallier, 2018, Cancer.

Allogeneic hematopoietic cell transplantation for advanced polycythemia vera and essential thrombocythemia.

H. Deeg, D. Porter, J. Cortes, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Thiotepa, busulfan and fludarabine compared to busulfan and cyclophosphamide as conditioning regimen for allogeneic stem cell transplant from matched siblings and unrelated donors for acute myeloid leukemia

M. Labopin, I. Yakoub-Agha, A. Nagler, 2018, American journal of hematology.

Thiotepa-busulfan-fludarabine compared to busulfan-fludarabine for sibling and unrelated donor transplant in acute myeloid leukemia in first remission

G. Mufti, M. Labopin, P. Chevallier, 2017, Oncotarget.

Dyslipidemia after allogeneic hematopoietic stem cell transplantation: evaluation and management.

Jeffrey B. Boord, J. Boord, B. Savani, 2010, Blood.

Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT

Hamadani, M. Norkin, W. Wood, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

High-dose total body irradiation and myeloablative conditioning before allogeneic hematopoietic cell transplantation: time to rethink?

M. Mohty, B. Savani, F. Malard, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Autologous Hematopoietic Stem Cell Transplantation for Male Germ Cell Tumors: Improved Outcomes Over 3 Decades.

P. Hari, R. Gale, Y. Nieto, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prediction of Hematopoietic Stem Cell Transplantation Related Mortality- Lessons Learned from the In-Silico Approach: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party Data Mining Study

Christoph Schmid, Jordi Esteve, Roni Shouval, 2016, PloS one.

W. Wood, H. Jim, J. Wingard, 2022, Transplantation and cellular therapy.

Long‐term follow‐up calendar

A. Tichelli, S. Hashmi, N. Majhail, 2021 .

What do we need to know about allogeneic hematopoietic stem cell transplant survivors?

M. Mohty, B. Savani, M. Mohty, 2016, Bone Marrow Transplantation.

Follow-up issues in survivors of hematologic malignancies - Current stance and future perspectives.

Ibrahim N. Muhsen, E. Estey, M. Bar, 2020, Blood reviews.

Measuring Immune Response to Commonly Used Vaccinations in Adult Recipients of Allogeneic Hematopoietic Cell Transplantation.

P. Ljungman, B. Savani, L. Kennedy, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Survival and Late Effects after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancy at Less than Three Years of Age.

M. Aljurf, L. Diller, R. Gale, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Preparative regimen dosing for hematopoietic stem cell transplantation in patients with chronic kidney disease: analysis of the literature and recommendations.

B. Savani, M. Bodge, M. S. Thompson, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Title : Thiotepa , busulfan and fludarabine compared to busulfan and cyclophosphamide as conditioning regimen for allogeneic stem cell transplant from matched siblings and unrelated donors for acute myeloid leukemia

M. Labopin, A. Nagler, M. Mohty, 2018 .

Comparative outcomes of myeloablative and reduced‐intensity conditioning allogeneic hematopoietic cell transplantation for therapy‐related acute myeloid leukemia with prior solid tumor: A report from the acute leukemia working party of the European society for blood and bone marrow transplantation

A. Ganser, J. Bourhis, M. Labopin, 2019, American journal of hematology.

Survival outcomes of allogeneic hematopoietic cell transplants with EBV‐positive or EBV‐negative post‐transplant lymphoproliferative disorder, A CIBMTR study

P. Hari, V. Brown, H. Heslop, 2019, Transplant infectious disease : an official journal of the Transplantation Society.

Management of high ferritin in long-term survivors after hematopoietic stem cell transplantation.

M. Mohty, B. Savani, E. Brissot, 2012, Seminars in hematology.

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report.

B. Sandmaier, M. Perales, A. Nagler, 2020, Blood advances.

Impact of conditioning intensity on outcomes of haploidentical stem cell transplantation for patients with acute myeloid leukemia 45 years of age and over

M. Labopin, D. Blaise, A. Nagler, 2019, Cancer.

Introduction: Why alternative donor transplantation and what are the different options and current challenges?

M. Mohty, B. Savani, 2016, Seminars in hematology.

Comparing outcomes of a second allogeneic hematopoietic cell transplant using HLA-matched unrelated versus T-cell replete haploidentical donors in relapsed acute lymphoblastic leukemia: a study of the Acute Leukemia Working Party of EBMT

M. Labopin, D. Blaise, A. Nagler, 2021, Bone Marrow Transplantation.

Lower Graft-versus-Host Disease and Relapse Risk in Post-Transplant Cyclophosphamide-Based Haploidentical versus Matched Sibling Donor Reduced-Intensity Conditioning Transplant for Hodgkin Lymphoma.

M. Perales, M. Aljurf, J. Bolaños-Meade, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Management of Sickle Cell Intrahepatic Cholestasis: An Argument in Favor of Automated Exchange Transfusion

B. Savani, B. Adkins, G. Booth, 2019, Clinical hematology international.

Irradiation‐free, T‐cell replete haploidentical transplant for Fanconi anaemia, weighing the benefits

B. Savani, J. Connelly, 2022, British journal of haematology.

Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study

M. Aljurf, J. Szer, R. Gale, 2020 .

The Intersection of Photopheresis and COVID-19 Vaccination

B. Savani, G. Booth, 2021, Transplantation and Cellular Therapy.

Factors influencing the late phase of recovery after bone mineral density loss in allogeneic stem cell transplantation survivors

J. Barrett, M. Battiwalla, B. Savani, 2016, Bone Marrow Transplantation.

Post-Transplant Cyclophosphamide after Matched Sibling, Unrelated and Haploidentical Donor Transplants in Patients with Acute Myeloid Leukemia, a Comparative Study of the ALWP EBMT

D. Blaise, A. Nagler, M. Mohty, 2019, Blood.

Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United States.

M. Krem, Stephanie J. Lee, K. Syrjala, 2021, Transplantation and cellular therapy.

Survivorship issues after transplantation

B. Savani, M. Jagasia, Vanessa E. Kennedy, 2017 .

Geographic distance is not associated with inferior outcome when using long-term transplant clinic strategy.

Heidi Chen, A. Kassim, B. Savani, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Ferritin and FerriScan in HCT recipients.

B. Savani, 2013, Blood.

How do I manage hyperglycemia/post-transplant diabetes mellitus after allogeneic HSCT

H. Einsele, A. Tichelli, N. Majhail, 2016, Bone Marrow Transplantation.

Outcome, toxicity profile and cost analysis of autologous stem cell mobilization

A. Pickard, A. Neff, B. Savani, 2011, Bone Marrow Transplantation.

Hosting an Unruly Guest: The Impact of Late Acute and Chronic Graft-versus-Host Disease.

B. Savani, M. Byrne, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Is There Still a Role for Macrolide Therapy

Sarfraz A. Saleemi, A. Kassim, B. Savani, 2015 .

Upfront autologous hematopoietic stem cell transplantation consolidation for patients with aggressive B‐cell lymphomas in first remission in the rituximab era: A systematic review and meta‐analysis

B. Savani, Ambuj Kumar, T. Reljic, 2019, Cancer.

Regulatory T-cell depletion does not prevent emergence of new CD25+ FOXP3+ lymphocytes after antigen stimulation in culture.

D. Douek, D. Ambrozak, J. Melenhorst, 2008, Cytotherapy.

Repair of impaired pulmonary function is possible in very-long-term allogeneic stem cell transplantation survivors.

C. Hourigan, A. Barrett, M. Battiwalla, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Splenic infiltrates in acute lymphoblastic leukemia

S. Shukla, B. Savani, P. Madan, 1994, American journal of hematology.

Six Month Freedom from Treatment Failure is an Important Endpoint for Acute Graft-Versus-Host Disease Clinical Trials

Heidi Chen, A. Kassim, J. Greer, 2013, Bone Marrow Transplantation.

Does extra alemtuzumab remove the graft-versus-leukemia effect after allogeneic stem cell transplantation in chronic lymphocytic leukemia?

B. Savani, S. Goodman, N. Reddy, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Maintenance tyrosine kinase inhibitors following allo-HCT for chronic myeloid leukemia: A CIBMTR Study.

M. Aljurf, J. Szer, R. Gale, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Vaccinations Efficacy in Long Term Survivors After Allogeneic Stem Cell Transplantation: Implication of Repeat Vaccinations and Documenting Vaccination Efficacy.

A. Kassim, J. Greer, B. Savani, 2009 .

Transfusion Support in Patients with Hematologic Disease: New and Novel Transfusion Modalities.

D. Stroncek, B. Savani, S. Panch, 2019, Seminars in hematology.

Transfusion support in patients with hematologic disease: Transfusions in special clinical circumstances.

D. Stroncek, B. Savani, S. Panch, 2020, Seminars in hematology.

Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation

M. Norkin, R. Vij, M. Horowitz, 2018, Bone Marrow Transplantation.

A perspective on complementary/alternative medicine use among survivors of hematopoietic stem cell transplant: Benefits and uncertainties

M. Mohty, S. Hashmi, M. Litzow, 2015, Cancer.

Varicella Zoster Virus Reactivation in Adult Survivors of Hematopoietic Cell Transplantation: How Do We Best Protect Our Patients?

P. Ljungman, B. Savani, Catherine J. Lee, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

B. Savani, W. Chinratanalab, Brent E Salvig, 2019, Clinical hematology international.

Outcomes of a novel rituximab-based non-myeloablative conditioning regimen for hematopoietic cell transplantation in severe aplastic anemia

A. Kassim, J. Greer, B. Savani, 2018, Bone Marrow Transplantation.

Adapting the HCT-CI Definitions for Children, Adolescents, and Young Adults with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation.

M. Sorror, M. Krem, M. Pasquini, 2022, Transplantation and Cellular Therapy.

Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemia

A. Ganser, M. Labopin, I. Yakoub-Agha, 2020, Blood Cancer Journal.

Fludarabine/TBI 8 Gy versus fludarabine/treosulfan conditioning in patients with AML in first complete remission: a study from the Acute Leukemia Working Party of the EBMT

M. Labopin, A. Nagler, M. Mohty, 2023, Bone Marrow Transplantation.

Prospective trial of minimal residual disease assessment by multiparametric flow cytometry for multiple myeloma in the era of bortezomib-based chemotherapy

Heidi Chen, A. Kassim, C. Mosse, 2018, Bone Marrow Transplantation.

Survival advantage of treosulfan plus fludarabine (FT14) compared to busulfan plus fludarabine (FB4) in active acute myeloid leukemia post allogeneic transplantation: an analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP).

M. Labopin, I. Yakoub-Agha, A. Nagler, 2023, Bone marrow transplantation.

Efficacy of High-Dose Therapy and Autologous Hematopoietic Cell Transplantation in Gray Zone Lymphoma: A US Multicenter Collaborative Study.

S. Forman, J. Chavez, B. Shah, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

American Society for Transplantation and Cellular Therapy Infectious Disease Guidelines: Preface to the Series.

G. Papanicolaou, M. Boeckh, R. Chemaly, 2021, Transplantation and cellular therapy.

Refusing blood transfusions from COVID‐19‐vaccinated donors: are we repeating history?

B. Savani, Lori A. Bibb, G. Booth, 2021, British Journal of Haematology.

Blood bans and COVID-19: Government attempts to influence medicine and science threaten us all.

B. Savani, B. Adkins, Laura D Stephens, 2023, American journal of clinical pathology.

Trading tissues for freedom: incentivizing stem cell and solid organ donation in the incarcerated population

B. Savani, B. Adkins, Lori A. Bibb, 2023, Bone Marrow Transplantation.

Critical Illness Risk and Long-Term Outcomes Following Intensive Care in Pediatric Hematopoietic Cell Transplant Recipients

M. Sorror, O. Ringdén, K. Myers, 2023, medRxiv.

Recombinant factor VIIa to treat diffuse alveolar hemorrhage following allogeneic stem cell transplantation.

B. Savani, A. Barrett, A. Shenoy, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Correction: Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT

M. Aljurf, R. Gale, N. Callander, 2019, Bone Marrow Transplantation.

SECOND MALIGNANCIES AFTER AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION IN CHILDREN

W. Wood, M. Sorror, J. Wingard, 2012, Bone Marrow Transplantation.

Building a transplantation physician workforce for growing need: recruitment starts during residency.

E. Wulff-Burchfield, B. Savani, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis

I. Yakoub-Agha, M. Aljurf, R. Gale, 2023, Blood advances.

Personalizing rabbit anti-thymocyte globulin therapy for prevention of graft-versus-host disease after allogeneic hematopoietic cell transplantation: is there an optimal dose?

A. Nagler, M. Mohty, B. Savani, 2019, Bone Marrow Transplantation.

Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis.

Sonali M. Smith, P. Hari, P. Armand, 2016, Journal of Clinical Oncology.

First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation.

J. Wingard, K. Ballen, Y. Nieto, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcomes after use of two standard ablative regimens in patients with refractory acute myeloid leukaemia: a retrospective, multicentre, registry analysis.

M. Labopin, A. Nagler, M. Mohty, 2015, The Lancet. Haematology.

Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.

J. Cortes, M. Aljurf, J. Szer, 2013, Blood.

Primitive quiescent CD34+ cells in chronic myeloid leukemia are targeted by in vitro expanded natural killer cells, which are functionally enhanced by bortezomib.

K. Keyvanfar, S. Adams, N. Hensel, 2009, Blood.

Tissue-specific regulatory T cells: biomarker for acute graft-vs-host disease and survival.

J. Crowe, M. Rock, S. Yoder, 2012, Experimental hematology.

J. Wingard, B. Shaw, H. Lazarus, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Epigenetic landscape of the TERT promoter: a potential biomarker for high risk AML/MDS

B. Dumitriu, K. Rezvani, Xingmin Feng, 2016, British journal of haematology.

The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen.

S. Montoto, Sonali M. Smith, D. Maloney, 2015, Biology of Blood and Marrow Transplantation.

Extracorporeal photopheresis versus anticytokine therapy as a second-line treatment for steroid-refractory acute GVHD: a multicenter comparative analysis.

M. Robin, N. Russell, H. Greinix, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysis.

Sonali M. Smith, J. Bolaños-Meade, Z. DeFilipp, 2018, Blood advances.

Maintenance therapies for Hodgkin and non-Hodgkin lymphomas after autologous transplantation: A consensus project of ASBMT, CIBMTR and LWP-EBMT.

M. Perales, B. Savani, A. Moskowitz, 2022 .

Preparative regimen dosing for hematopoietic stem cell transplantation in patients with chronic kidney disease: analysis of the literature and recommendations.

B. Savani, M. S. Thompson, Srividya Reddy, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation

S. Solomon, D. Blaise, A. Nagler, 2019, Bone Marrow Transplantation.

Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia.

U. Popat, M. Kalaycio, Z. DeFilipp, 2018, Blood advances.

The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia.

M. Norkin, B. Sandmaier, B. George, 2019, Blood advances.

B. Sandmaier, M. Aljurf, M. Grunwald, 2019, Haematologica.

Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia.

M. Norkin, R. Vij, W. Wood, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Sexual health in hematopoietic stem cell transplant recipients

M. Mohty, B. Shaw, P. Stratton, 2015, Cancer.

A perspective on complementary/alternative medicine use among survivors of hematopoietic stem cell transplant: Benefits and uncertainties

M. Mohty, S. Hashmi, M. Litzow, 2015, Cancer.

Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantation.

J. Esteve, J. Bourhis, F. Baron, 2015, Blood.

Subsequent neoplasms and late mortality in children undergoing Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases allogeneic transplantation for nonmalignant diseases

M. Norkin, B. Alter, M. Flowers, 2022 .

Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies.

K. Rezvani, A. Barrett, S. Mielke, 2007, Blood.

Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome.

R. Vij, W. Wood, J. Cortes, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A. Kassim, J. Greer, B. Savani, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia.

M. Aljurf, J. Szer, R. Gale, 2019, Blood advances.

Lower GVHD and relapse risk in PTCy-based Haploidentical vs Matched Sibling Donor RIC Transplant for Hodgkin Lymphoma

M. Aljurf, J. Bolaños-Meade, Y. Nieto, 2019 .

Beyond ruxolitinib in steroid‐refractory acute graft‐versus‐host disease

B. Savani, I. Pusic, Catherine J. Lee, 2021, British journal of haematology.

Expression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissues

C. Hourigan, A. Barrett, N. Hensel, 2014, Leukemia.

Superior long-term outcome of patients with early transformation of non-Hodgkin lymphoma undergoing stem cell transplantation.

O. Oluwole, J. Greer, B. Savani, 2012, Clinical lymphoma, myeloma & leukemia.

Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Hematopoietic Cell Transplantation.

M. Norkin, M. Perales, S. Mineishi, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Looking Ahead: Clinical Hematology International Turns One

A. Nagler, M. Mohty, B. Savani, 2020, Clinical hematology international.

Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis

M. Aljurf, R. Gale, K. Ballen, 2023, Haematologica.

Allogeneic and other innovative chimeric antigen receptor platforms

B. Savani, S. Sengsayadeth, Bhagirathbhai R. Dholaria, 2024, Clinical hematology international.

Sexual health and emotional wellbeing of patients with haematological malignancies: general review.

B. Savani, Tamim Alsuliman, E. Brissot, 2024, The Lancet. Haematology.